Services

TheraGenetics creates innovative pharmaceutical partnerships for drugs in development and for drug repositioning.

Using the principles and technology on which we have established our company, TheraGenetics creates partnerships with drug development enterprises to investigate the genetic variants responsible for heterogeneous response or toxicity of CNS drugs in development or marketed.

These partnerships allow drugs to be targeted to the correct patient group through:

• Clinical Trial Patient Selection:

  TheraGenetics pharmacogenetic diagnostics guide the selection of patients for clinical trials.

• Drugs Rescue and Repositioning:

  TheraGenetics partnerships integrate pharmacogenetics into drug development and safety surveillance processes, offering the potential to rescue drugs abandoned in late stage clinical trials and also to assist companies in repositioning drugs.

• Combination Therapeutics:

  TheraGenetics works in partnership with pharmaceutical companies to develop companion diagnostics which allow targeted use of the particular therapeutic.